4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide

Basic Information

View in Editor

CAS Number

870070-55-6

Molecular Formula

C19H26N4O4S

Molecular Weight

406.51 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Density

1.374

SMILES

View in Editor

COc1ccc(c2c1nc(s2)NC(=O)N1CCC(CC1)(C)O)N1CCOCC1

InChI

InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)

InChIKey

XNBRWUQWSKXMPW-UHFFFAOYSA-N

LogP

2.520200000000001

Topological Polar Surface Area

87.16 Å²

Hydrogen Bond Donor/Acceptor

2 / 8

Complexity

554

Safety Information

View Safety Information

GHS Hazard Pictograms

H302

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

Synonyms & References

English

4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl]-4-methyl-1-piperidinecarboxamide
Tozadenant
4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide
4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzo-thiazolyl]-4-methyl-1-piperidinecarboxamide
SYN-115
SYN115
Tozadenant http:
www.gh-reagent.com
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
D9K857J81I
AK103300
C19H26N4O4S
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo(d)thiazol-2-yl)-4-methylpiperidine-1-carboxamide
4-hydroxy

MDL Number

MFCD21642026

FAQ

What regulatory guidelines apply to 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6)?

The compound 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6) may need to comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous communication. In the European Union, it must adhere to REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations. In the USA, it may be subject to FDA (Food and Drug Administration) and EPA (Environmental Protection Agency) guidelines depending on its intended use.

Are there alternatives to 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6) in synthesis?

For the synthesis of 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6), several alternatives can be considered. Researchers often use analogs such as 4-morpholinyl-benzothiazoles or 4-methoxy-1,3-benzothiazoles as starting materials. Common alternative reagents include morpholine, methoxy compounds, and piperidine derivatives. These can provide similar functional groups or structural motifs for different synthesis pathways.

What is the market or research trend for 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6)?

The market and research trends for 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6) are driven by its potential applications in pharmaceuticals and agrochemicals. Recent studies focus on its bioactivity, particularly in antifungal and antiviral properties. Market trends indicate an increasing demand due to its unique chemical structure and potential therapeutic uses. Researchers are also investigating its synthetic routes and environmental impact.

How should waste containing 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6) be handled?

Waste containing 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-1,3-benzothiazol-2-yl]-4-methyl-1-piperidinecarboxamide (CAS: 870070-55-6) should be collected in appropriate containers and stored under controlled conditions to prevent degradation or contamination. Incineration is a common disposal method, but professional waste disposal services are recommended to ensure compliance with environmental regulations. Proper handling includes wearing protective equipment and following local waste management guidelines to minimize environmental impact.